Vitamin E supplementation reduces cardiovascular events in middle-aged patients with type 2 diabetes and the haptoglobin (Hp) 2-2 genotype, Israeli researchers report in the February issue of Arteriosclerosis, Thrombosis, and Vascular Biology. Dr. Andrew P. Levy of Technion-Israel Institute of Technology, Haifa and colleagues note that Hp is a determinant of cardiovascular